On Jan 27, Freeport-McMoRan Inc. (NYSE:FCX) reported a fourth-quarter loss due to net charges of $3.1 billion, mainly related to the value of its oil and gas properties and goodwill impairment. The company said it expected capital expenditure of about $6 billion in 2015, down $1.2 billion from its 2014 spending, mainly due to a 34 percent cut in oil and gas spending. On Friday shares of Freeport-McMoRan Inc. (NYSE:FCX) closed at $18.85. Company’s sales growth for last 5 years was 7.30% and EPS growth for next 5 years is recorded as 37.76%.
Dynavax Technologies Corporation (NASDAQ:DVAX) announced the appointment of Laura Brege to its Board of Directors and Audit Committee. Denise Gilbert, a director and the Chair of the Audit Committee since 2004, will retire from her positions with the company following the next Audit Committee meeting, whereupon Ms. Brege will become Chair of the Committee. On Friday shares of Dynavax Technologies Corporation (NASDAQ:DVAX) closed at $16.14. Company’s sales growth for last 5 years was -21.20%.
Parsley Energy (NYSE: PE) announced that it has entered into an agreement to sell 14,885,797 shares of its Class A common stock in a private placement, which is expected to result in approximately $231 million of gross proceeds and $224 million of net proceeds (after deducting placement agent commissions and the Company’s estimated expenses). Parsley Energy, Inc. (NYSE:PE) in last trading activity decreased -0.17% to close at $17.59. Company weekly performance is 4.89% while its quarterly performance stands at 11.12%. Parsley Energy, Inc. (NYSE:PE) is -31.56% away from its 52 week high.
On Feb 04, GlaxoSmithKline plc (NYSE:GSK), reported fourth-quarter earnings that beat analyst estimates as it sold more HIV and cancer drugs. On last trading day GlaxoSmithKline plc (NYSE:GSK) advanced 0.11% to close at $46.00. Its volatility for the week is 1.22% while volatility for the month is 1.31%. GSK’s sales growth for past 5 years was 1.70% and its EPS growth for past 5 years was 4.60%. GlaxoSmithKline plc (NYSE:GSK) monthly performance is 9.24%.
On Jan. 29, NetSuite Inc. (NYSE: N), announced operating results for its fourth quarter and fiscal year ended December 31, 2014. Total revenue for the fourth quarter of 2014 was $157.9 million, representing a 37% increase over the prior year. Total revenue for the year was $556.3 million, a year-over-year increase of 34%. On last trading day NetSuite Inc. (NYSE:N) fell -0.55% to close at $96.40. Its volatility for the week is 2.56% while volatility for the month is 3.42%. N’s sales growth for past 5 years was 22.10% and its EPS growth for past 5 years was -29.60%. NetSuite Inc. (NYSE:N) monthly performance is -8.04%.